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ApoptosisEndoplasmic reticulum (ER) stress is implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD).
TRC8 is an ER-resident E3 ligase with roles inmodulating lipid and protein biosynthesis. In this study we showed
that TRC8 expression was downregulated in steatotic livers of patients andmice fedwith a high fat diet (HFD) or
a methionine and choline deﬁcient (MCD) diet. To investigate the impact of TRC8 downregulation on steatosis
and the progression to non-alcoholic steatohepatitis (NASH), we placed TRC8 knockout (KO) mice and wild
type (WT) controls on a HFD or MCD diet and the severities of steatosis and NASH developed were compared.
We found that TRC8 deﬁciency did not signiﬁcantly affect diet-induced steatosis. Nevertheless, MCD diet-
induced NASH as characterized by hepatocyte death, inﬂammation and ﬁbrosis were exacerbated in TRC8-KO
mice. The hepatic ER stress response, as evidenced by increased eIF2α phosphorylation and expression of ATF4
and CHOP, and the level of activated caspase 3, an apoptosis indicator, were augmented by TRC8 deﬁciency.
The hepatic ER stress and NASH induced in mice could be ameliorated by adenovirus-mediated hepatic TRC8
overexpression. Mechanistically, we found that TRC8 deﬁciency augmented lipotoxic-stress-induced unfolded
protein response in hepatocytes by attenuating the arrest of protein translation and the misfolded protein deg-
radation. These ﬁndings disclose a crucial role of TRC8 in the maintenance of ER protein homeostasis and its
downregulation in steatotic liver contributes to the progression of NAFLD.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Nonalcoholic fatty liver disease (NAFLD) is the most common cause
of chronic liver disease associated withmetabolic syndrome in civilized
countries [1–3]. Although steatosis caused by the accumulation of tri-
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du.tw (S.-K. Shyue),non-alcoholic steatohepatitis (NASH) characterized by hepatic injury,
inﬂammation and ﬁbrosis, and eventually advance to cirrhosis and he-
patocellular carcinoma [1–3]. Nevertheless, the pathological mecha-
nisms underlying NASH are not completely understood. Over the past
decade, accumulative evidence has supported the involvement of endo-
plasmic reticulum (ER) stress in the progression of NAFLD [4–6]. In
addition to regulating the quantity of secretary and membrane protein
synthesis, ER is well known for its crucial role in protein quality control
bywhich the unfolded ormisfolded proteins are removed anddegraded
via a process called ER-associated degradation [7]. Disruption of the
ER homeostasis characterized by the accumulation of unfolded or
misfolded proteins within ER is commonly seen in the livers of experi-
mental animals and human patients with NAFLD [4–6]. When ER stress
is induced, it activates the unfolded protein response (UPR) to reduce
global protein synthesis and facilitate the capacity of protein folding
and degradation to restore ER homeostasis. However, prolonged UPR
caused by the aggravated ER stress fails to promote cell survival but ac-
tivates the apoptotic pathway ultimately leading to cell death and in-
ﬂammatory response seen in various pathophysiological conditions,
including NASH [8,9]. Apparently, increasing our understanding of the
mechanism underlying the persistent ER stress in NASH could pave
the way to a new therapeutic strategy for NAFLD.
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sociated with hereditary renal cancer [10]. In addition to its tumor sup-
pressive function [11,12], TRC8 has been shown to regulate cholesterol
and fatty acid biosynthesis by stimulating the destabilization of the
ER-bound sterol regulatory element-binding proteins (SREBPs) [13],
hindering ER to Golgi transport of SREBP-2 [14], andmediating the deg-
radation of HMG-CoA reductase [15]. Moreover, studies in Drosophila
andmammalian cells revealed that TRC8 suppresses protein translation
through targeting eIF3f and eIF3h for degradation [11]. In view of its
multifaceted roles, dysregulation of TRC8 expression may have an im-
pact on cellular homeostasis. In the present study, we show that TRC8
expression was downregulated in steatotic livers of human patients
and mice placed on a high-fat diet (HFD) or methionine and choline
deﬁcient (MCD) diet. Moreover, MCD diet-induced NASH was more
severe in TRC8 knockout (KO) mice comparing to their wild type
(WT) controls, supporting the implication of TRC8 in NAFLD progres-
sion. Additional experiments were performed to disclose the mecha-
nisms involved.
2. Materials and methods
2.1. Human liver samples
Fresh frozen non-tumorous liver samples, including nine samples
with non-alcoholic fatty liver disease: 4 with mild (10–20%) fatty
change and 5 with moderate to severe (30–75%) fatty change, and an-
other ﬁve samples with minimal (0–1%) fatty change were retrieved
from the Human Biobank of National Cheng Kung University Hospital.
The severity of fatty change was evaluated and graded corresponding
to the percentage of macrovesicular fat accumulation in liver parenchy-
ma. These samples were collected from patients whowere serologically
negative for HBsAg and HCV antibody and had primary liver cancer un-
dergoing hepatectomy (12 cases had HCC and 2 cases had cholangiocar-
cinoma). Eleven patients were male and three were female and the
mean agewas 65.9 years old (range 53 ~ 83 years old). Studies were ap-
proved by the Institutional Review Boards of both National Cheng Kung
University (A-ER-103-285) and Academia Sinica (AS-IRB-BM 14064
v.1) Taiwan.
2.2. Animal experiments
The mouse ES cells (C57BL/6N-A origin) carrying TRC8 deletion al-
leles (Rnf139 DPGS00168_A_D07) were purchased from KOMP (knock-
outmouse project repository) (http://www.komp.org) in UCDavis, USA
and used for the establishment of amouse linewith TRC8 deﬁciency in a
C57BL/6J genetic background. Brieﬂy, the ES cells were injected into
mouse blastocysts to generate chimeric mice. The germline transmis-
sion and genotype of the mouse line containing the targeted deletion
were conﬁrmed by a genomic DNA-polymerase chain reaction (PCR)
assay using two pairs of primers to amplify the inserted neomycin resis-
tance gene (5′-TGTTCGGCTATGACTGGGCACA-3′ and 5′-GAGCAAGGTG
AGATGACAGGAGAT-3′) and a deleted TRC8 fragment from the WT
gene (5′-GTTCTGATCTTGTCACAGCGATC-3′ and 5′-AGGTTAGCTGCAGA
ACGATGAGT-3′), respectively. PCR products were then subjected to
1.5% agarose gel electrophoresis and visualized by ethidium bromide
staining (Supplementary Fig. 1). To induce steatosis, C57BL/6J mice,
TRC8-KO mice and their WT control mice (male, 8 weeks old) were
fed with chow or HFD (60 kcal% fat, D12492, Research Diets) for 12
weeks. To induce NASH, mice were fed with chow or a MCD diet for 6
weeks. For the sodium 4-phenylbutyrate (PBA) treatment experiment,
MCD diet-fed mice in each genotype were divided into two groups
with one group of mice receiving intraperitoneal injection of saline
and another group receiving PBA dissolved in saline (Sigma-
Aldrich, St. Louis, MO; 100 mg/kg body weight) every three days
starting from the second week of MCD diet feeding. For the adenovirus
(Adv)-mediated gene transfer experiment, C57BL/6Jmicewere fedwiththeMCD diet for 3 weeks, followed by intravenous injection of saline or
1 × 109 plaque-forming units (pfu)/mouse of empty control Adv or Adv
bearing human TRC8 cDNA (Adv-TRC8) via tail vein. Mice were contin-
uously fed with the MCD diet for 3 weeks prior to sacriﬁce. All mice
were kept on a 12 h light–dark cycle and allowed free access to food
and water. All experimental procedures with animals were approved
by the Institutional Animal Care and Utilization Committee of the
Academia Sinica, Taiwan (IACUC protocol ID: 12-02-320).
2.3. DNA constructs
pIRES-NHK-HA vector bearing misfolded α1-antitrypsin variant-
null Hong Kong was kindly provided by Dr. Xin Chen of the National
Health Research Institutes, Taiwan. Control Adv and the Adv-TRC8 bear-
ing human TRC8 genewere prepared using AdEasy™ Adenoviral Vector
System (Agilent Technologies, La Jolla, CA, USA) according to the
manufacturer's instruction.
2.4. Cell culture
Human HepG2 and mouse Hepa 1-6 hepatoma cell lines were cul-
tured in Dulbecco's modiﬁed Eagle's medium (Invitrogen, Grand Island,
NY) containing 10% fetal bovine serum (FBS). Primary hepatocyteswere
isolated fromWT and TRC8-KOmice using collagenase perfusion as de-
scribed previously [16] seeded on a collagen-coated plate (0.5 μg type I
collagen/cm2) and cultured in Dulbecco's modiﬁed Eagle's medium/F12
medium containing 10% FBS.
2.5. Quantitative reverse transcription-polymerase chain reaction
(RT-PCR)
Total RNAswere isolated and quantitative RT-PCRwas performed as
described previously [17]. The primers used were listed in Supplemen-
tary Table 1.
2.6. Hepatic TG and cholesterol measurements
Hepatic lipid was extracted as described previously [17]. TG and
cholesterol concentrations were determined using TG and cholesterol
assay kits (Cayman, Ann Arbor, MI).
2.7. Anti-mouse TRC8 antibody production
A cDNA fragment encoding amino acids 591-668 ofmouse TRC8was
subcloned into pGEX-4T-1 vector. The recombinant TRC8 peptide fused
with glutathione-s-transferase (GST) at N-terminus was induced in
E. coli, puriﬁed by glutathione afﬁnity resin, and used as an antigen for
antibody production in rabbit. TRC8 speciﬁc antibody was puriﬁed
from the serum of an immunized rabbit with an afﬁnity column conju-
gatedwith recombinantGST-TRC8 and stored in aliquots in 50% glycerol
at−20 °C. The speciﬁcity of the antibody was conﬁrmed by Western
blot analysis using recombinant GST and GST-TRC8 proteins and liver
tissue lysates fromWT and TRC8-KO mice (Supplementary Fig. 2).
2.8. Western blot analysis
Tissue and cell lysates were prepared as described previously [17].
The protein samples were separated by electrophoresis in 10% SDS-
polyacrylamide gels and transferred to a polyvinylidene diﬂuoride
membrane. Immunoblotting was performed as described previously
[17]. Antibodies used included anti-GRP78, anti-ubiquitin, anti-ATF4
(from Santa Cruz, Santa Cruz, CA), anti-p-eIF2α, anti-eIF2, anti-CHOP,
anti-cleaved caspase 3 (from Cell Signaling, Danvers, MA), anti-α-
smooth muscle actin (α-SMA) (DAKO, Carpinteria, CA), and anti-
hemagglutinin (HA) (Abcam, Cambridge, MA).
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assay
TUNEL assay was performed using a commercial kit according to the
manufacturer's instructions (Roche Diagnostics, Basel, Switzerland).
Brieﬂy, liver parafﬁn-sections (5 μm) were incubated with proteinase
K (RNase-free, Invitrogen, Grand Island, NY) at room temperature for
15 min. Primary hepatocytes were ﬁxed with 4% paraformaldehyde
for 20 min at room temperature and permeabilized with 0.1%
Triton X-100. Tissue sections or cells were then incubated with TUNEL
reaction mixture for 1 h at 37 °C in the dark. The nuclei were stained
with 4,6-diamidino-2-phenylindole, and TUNEL-positive cells were ex-
amined and counted under a high power ﬁeld (200×) by ﬂuorescence
microscopy.
2.10. Histopathological analysis
Parafﬁn-embedded or frozen livers were sectioned (5 μm) and the
severity of steatosis was assessed by hematoxylin and eosin (H&E) or
Oil Red staining as indicated. Hepatic ﬁbrosis was examined by Sirius
Red staining and quantiﬁed with Image J software (NIH, shareware).
For the assessment of macrophage inﬁltration, the liver sections were
blocked with 5% normal goat serum and 3% bovine serum albumin,
followed by incubation with rat anti-F4/80 (GeneTex, Irvine, CA) at
room temperature for 1 h. After a phosphate-buffered saline wash, the
antigen–antibody complex was detected by incubation with horserad-
ish peroxidase-conjugated goat anti-rat IgG (Santa Cruz, Santa Cruz,
CA) and stained with 3,3′-diaminobenzidine. Prior to mounting, sec-
tions were counterstained with hematoxylin. F4/80+-cells were detect-
ed and counted under a high power ﬁeld (200×) by light microscopy.
2.11. Transmission electron microscopy
Liver tissues were ﬁxed in 0.1M phosphate buffer, pH 7.4 containing
2% paraformaldehyde and 2.5% glutaraldehyde at 4 °C for 2 h. After a
wash with 0.1 M imidazole buffer, tissue pieces were post-ﬁxed with
2% osmium tetroxide in 0.1 M imidazole buffer at 4 °C, dehydrated
through a graded series of ethanol solutions, rinsed in propylene
oxide, and embedded in epoxy resin. Thin sections were prepared
using a Reichert Ultracutmicrotome (Leica, Deerﬁeld, IL), and examined
using a Philips CM-12S electron microscope (Philips Electronic Instru-
ments, Mahwah, NJ).
2.12. Surface sensing of translation (SUnSET) assay
Primary hepatocyteswere treatedwith orwithout 400 μMpalmitate
for 24 h, followed by incubation with 10 μg/ml puromycin for 10 min.
Cell lysates were prepared and the incorporation of puromycin into
nascent proteins was examined by Western blot analysis using anti-
puromycin antibody (Millipore, Billerica, MA).
2.13. Cycloheximide (CHX) chase assay
Primary hepatocytes (2 × 105/well) seeded in a 6-well plate were
transfected with 1 μg of control or pIRES-NHK-HA vector using Lipofec-
tamine 2000 (Invitrogen, Grand Island, NY). At 24 h post transfection,
cells were treated with 10 μg/ml CHX for indicated times prior to har-
vest. Cell lysates were prepared and the decline of the pIRES-NHK-HA
protein was examined by Western blot analysis.
2.14. Immunoprecipitation
Cell lysates prepared from pIRES-NHK-HA vector-transfected hepa-
tocytes were subjected to immunoprecipitation using anti-HA afﬁnity
gel (Sigma, St. Louis, MO) as described previously [18].2.15. Statistical analysis
Data were expressed as mean ± SE. Statistical analysis was
performed with one-way ANOVA. A P-value of b0.05 was considered
statistically signiﬁcant.
3. Results
3.1. TRC8 is downregulated in steatotic liver
To examine whether hepatic TRC8 expression is altered in NAFLD,
C57BL/6J mice were placed in a HFD or MCD diet to induce hepatic
steatosis and TRC8 gene expression was determined by quantitative
RT-PCR. As shown in Fig. 1A, the hepatic TRC8 mRNA level detected in
HFD or MCD diet-fed mice was signiﬁcantly lower than that of chow
diet-fed control mice. Likewise, Western blot analysis demonstrated
that TRC8 protein expression was reduced in livers of HFD and MCD-
fed mice comparing to their controls (Fig. 1B). TRC8 downregulation
again was observed in steatotic liver biopsies of human patients. As
shown in Fig. 1C & D, the levels of TRC8 mRNA and protein were
substantially lower in livers with higher degrees of fatty change.
3.2. ER stress induces TRC8 downregulation in hepatocytes
To elucidate the potentialmechanism underlying TRC8 downregula-
tion in steatotic liver, HepG2 and Hepa 1-6 hepatoma cell lines were
treated with lipotoxic saturated fatty acid, palmitate, or other ER stress
inducers, tunicamycin and thapsigargin, as indicated for 24 h. As dem-
onstrated in Fig. 2A & B, TRC8 mRNA and protein expression levels in
both cell lines were reduced by treatment with these agents. Notably,
TRC8 downregulation was also evident in cells treated with stearate
but not monounsaturated fatty acids, such as palmitoleate and oleate
(Fig. 2C).
3.3. TRC8 deﬁciency exacerbates diet-induced liver injury without affecting
steatosis
To explore the impact of TRC8 downregulation on NAFLD progres-
sion, we generated TRC8-KO mice to elucidate the effect of TRC8
deﬁciency on disease development. TRC8-KOmicewere born inMende-
lian ratio and displayed no obvious phenotype as examined at 3months
of age (Supplementary Fig. 3). When TRC8 KO mice and WT controls
were placed on a HFD for 12 weeks, the body weight gains were
similar between two groups (Supplementary Fig. 4A). Histological ex-
amination of liver sections and quantiﬁcation of hepatic TG and choles-
terol contents revealed no signiﬁcant difference in the extents of
steatosis between WT and TRC8-KO mice (Supplementary Fig. 4B &
C). Nevertheless, when hepatocyte apoptosis, which has a crucial role
in NAFLD progression, was assessed by TUNEL staining, the results
showed that the number of TUNEL+ cells was higher in the livers of
HFD-fed TRC8-KO mice comparing to WT controls (Supplementary
Fig. 4D). Moreover, Western blot analysis demonstrated that the level
of cleaved caspase 3, an indicator of apoptosis, was more evident in
the steatotic livers of TRC8-KO mice (Supplementary Fig. 4E). To assess
whether TRC8 deﬁciency also accelerates the hepatic injury in more ad-
vanced NAFLD, we placed WT and TRC8-KO mice on a MCD diet to in-
duce NASH. It was found that MCD diet-induced body weight loss and
hepatic steatosis were comparable between WT and TRC8-KO mice
(Fig. 3A–C). We also performed quantitative RT-PCR to assess the ex-
pression of genes associated with lipid synthesis. As shown in Fig. 3D,
the effect of the MCD diet on the expression of hepatic fatty acid syn-
thase (FAS), HMG-CoA reductase, phosphatidate phosphatase 2a
(Ppap2a) and DAG acyltransferase (Dgat1) inmicewas not signiﬁcantly
affected by TRC8 deﬁciency. However, TUNEL staining of liver sections
revealed that hepatocyte apoptosis was more prominent in MCD-fed
TRC8-KO mice comparing to their WT counterparts (Fig. 3E). Similarly,
Fig. 1. TRC8 expression is downregulated in fatty liver. (A & B) C57BL/6J mice were subjected to chow and HFD for 12 weeks (n= 4/group) or chow andMCD diets for 6 weeks (n= 6/
group). Hepatic TRC8mRNA (A) and protein (B) expression levelswere examined by quantitative RT-PCR andWestern blot analysis, respectively. Quantitative data representmean± SE.
*P b 0.01 vs chowdiet. (C&D) TRC8mRNA (C) andprotein (D) expressions inhuman liver biopsieswith various degrees of fatty changewere examined. The numbers of sampleswith 0–1,
10–20, and 30–75% of fatty change were 5, 4 and 5, respectively. Quantitative data represent mean ± SE. *P b 0.03 vs 0–1% fatty change.
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steatotic livers of TRC8-KO mice (Fig. 3F). These observations indicate
that TRC8 deﬁciency exacerbates hepatic injury without signiﬁcantly
affecting lipid metabolism in NAFLD.
3.4. Hepatic inﬂammation and ﬁbrosis are augmented by TRC8 deﬁciency
To further assess whether TRC8 deﬁciency promotes NASH devel-
opment, we examined the hepatic expression of genes related to in-
ﬂammation and ﬁbrosis in MCD-fed mice. As demonstrated in
Fig. 4A, the expressions of tumor necrosis factor-α (TNF-α), monocyte
chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2
(MMP-2), transforming growth factor-β (TGF-β), and collagen type
I-α1 induced in the steatotic livers were signiﬁcantly higher in TRC8-
KO mice than WT counterparts. Likewise, immunostaining of the liver
sections with antibody against F4/80, a marker of macrophages, re-
vealed that macrophage inﬁltration in the steatotic liver was more
prominent in TRC8-KO mice (Fig. 4B). Sirius Red staining also demon-
strated that the hepatic ﬁbrosis induced by theMCD diet was augmented
by TRC8 deﬁciency (Fig. 4C). In parallel, Western blot analysis demon-
strated a higher expression level of α-SMA, a marker of myoﬁbroblasts,
in the livers of MCD-fed TRC8-KO mice comparing to WT controls
(Fig. 4D). Collectively, these data demonstrate that TRC8 deﬁciency
exacerbates the progression of NASH in experimental mice.
3.5. TRC8 deﬁciency augments lipotoxicity-induced ER stress
The excessive and prolonged activation of ER stress caused by the
lipotoxic environment in fatty liver contributes to the induction of he-
patic injury and inﬂammation during the progression to NASH [19,20].
To examine whether TRC8 deﬁciency exacerbates ER stress responsein NASH, eIF2α phosphorylation and expression of ER stress markers,
including transcriptional factor ATF4, chaperone protein GPR78 and ap-
optotic inducer CHOP, in the livers of these mice were examined by
Western blot analysis. As demonstrated in Fig. 5A and Supplementary
Fig. 5, eIF2α phosphorylation was elevated in livers of MCD-fed mice
and was much higher in TRC8-KO mice. Likewise, the levels of ATF4,
GRP78 and CHOP protein expression were increased by the MCD diet
to greater extents in TRC8-KO mice comparing to WT counterparts.
Alongwith thebiochemical response, electronmicroscopic examination
of the liver sections revealed that the hepatic ERwas fragmented anddi-
lated in MCD diet-fed mice (Fig. 5B). Moreover, the accumulation of
electron dense protein aggregates in the ER lumen was evident in
steatotic hepatocytes of TRC8-KOmice. An inverse correlation between
TRC8 expression and ER stress response was also demonstrated in
human liver biopsies. As shown in Supplementary Fig. 6, the extents
of eIF2α phosphorylation and expression of ATF4 and CHOP were
much higher in liver tissues exhibiting greater fatty change but lower
TRC8 expression (Fig. 1D). The impact of TRC8 deﬁciency on ER stress
was further conﬁrmed by in vitro experiments showing that palmitate
induced higher levels of eIF2α phosphorylation, ATF4 and CHOP expres-
sion in primary hepatocytes isolated from TRC8-KOmice than fromWT
mice (Fig. 5C and Supplementary Fig. 7). Along with the enhanced ER
stress response, palmitate-induced caspase 3 cleavage and apoptotic
death were also much greater in TRC8-KO hepatocytes (Fig. 5C & D;
Supplementary Fig. 7).
3.6. TRC8 deﬁciency attenuates lipotoxic stress-induced protein synthesis
inhibition and misfolded protein degradation
TRC8 has been shown to suppress protein translation by promot-
ing eIF3 ubiquitination and degradation [11]. To examine whether
Fig. 2.ER stress induces TRC8downregulation. (A&B)HepG2 andHepa1-6 cellswere treatedwith palmitate (200 μM), tunicamycin (6 μM), or thapsigargin (100 nM) as indicated for 24h.
TRC8 mRNA expression (A) was quantiﬁed by quantitative RT-PCR. Data represent mean ± SE of 3 independent experiments. *P b 0.02 vs untreated control. TRC8 protein expression
(B)was examined byWestern blot analysis. Data shown are representative blots. (C)HepG2 cellswere treatedwith 200 μMof indicated fatty acids for 24h. TRC8 expressionwas examined
by Western blot analysis. TRC8 protein was quantiﬁed by densitometry and normalized to β-actin. Quantitative data represent mean ± SE of 3 independent experiments. *P b 0.01 vs
untreated control.
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patic ER stress during NASH development, we performed SUnSET
assay [21] to assess the effect of palmitate-induced stress on protein
translation in primary hepatocytes derived from WT and TRC8-KO
mice. As shown in Fig. 6A&B, the protein translation appeared to be
more active in TRC8-KO hepatocytes under normal condition. The
rate of protein translation was decreased by palmitate treatment in
both WT and TRC8-KO hepatocytes, whereas it remained higher in
TRC8-KO hepatocytes comparing to WT counterparts, indicating
that TRC8 deﬁciency attenuates lipotoxic ER stress-induced transla-
tional arrest in hepatocytes. Considering that TRC8 is an ER-resident E3 ligase, we then examined whether it impacts the degra-
dation of misfolded or unfolded proteins accumulated in the ER of
steatotic livers. To this end, both WT and TRC8-KO hepatocytes
were transfected with a cDNA construct bearing HA-tagged
misfolded α1-antitrypsin variant (ATNHK). The turnover rates of
ATNHK protein overexpressed in WT and TRC8-KO hepatocytes
were then determined by CHX chase assay. As shown in Fig. 6C&D,
the half-life of ATNHK in WT hepatocytes was much shorter than
that in TRC8-KO hepatocytes. Moreover, the level of ubiquitination
of the ATNHK protein immunoprecipitated from WT hepatocytes
was much higher than that from the TRC8-KO hepatocytes (Fig. 6E).
Fig. 3. TRC8 deﬁciency exacerbatesMCD diet-induced liver injury but not steatosis. WT and TRC8-KOmice (n= 6/group) were placed on chow orMCD diet for 6 weeks. (A) Bodyweight
changes were determined. *P b 0.01 vs chow diet-fed group of same genotype. (B) Representative Oil Red stains of liver sections. (C) Hepatic TG and cholesterol levels were determined.
*P b 0.01 vs chowdiet-fed group of same genotype. (D) ThemRNA levels of FAS, HMG-CoA reductase, Ppap2a, andDgat1were quantiﬁedby quantitativeRT-PCR. (E) Representative TUNEL
stains (red) of liver sections. The numbers of TUNEL+-cells in various groups were quantiﬁed. Data represent mean± SE. *P b 0.01 vs chow diet-fed group of same genotype; †P b 0.01 vs
MCD diet-fed WT group. (F) The levels of TRC8 and cleaved caspase 3 in various groups examined by Western blot analysis and quantiﬁed by densitometry. *P b 0.05 vs chow diet-fed
group of same genotype; †P b 0.02 vs MCD diet-fed WT group.
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Fig. 4.Hepatic inﬂammation and ﬁbrosis are augmented by TRC8 deﬁciency. WT and TRC8-KO mice were fed with chow or MCD diet for 6 weeks (n= 6/group). (A) The mRNA levels of
TNF-α, MCP-1, MMP-2, TGF-β and collagen type I-α1were quantiﬁed by quantitative RT-PCR. (B) Representative F4/80 immunostains of liver sections. Inﬁltrating F4/80+ cells in various
groups were quantiﬁed. (C) Representative Sirius Red stains of liver sections. Morphometric quantiﬁcation of the ﬁbrosis area was performed using Image J software. (D) Hepaticα-SMA
protein expressions in various groups examinedbyWestern blot analysis and quantiﬁedbydensitometry. Quantitative data representmean±SE. *P b 0.05 vs chowdiet-fed group of same
genotype; †P b 0.05 vs MCD diet-fed WT group.
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Fig. 5. TRC8 deﬁciency enhances hepatic ER stress. WT and TRC8-KOmice were fed with chow or MCD diet for 6 weeks. (A) The hepatic levels of p-eIF2α, ATF4, CHOP and GRP78 in in-
dicated groups ofmicewere examinedbyWestern blot analysis. (B) Representative transmission electronmicrophotographs of liver sections. The regions outlined by the black boxeswere
shown in higher-power views. ER is indicated by an arrow. The electron-dense protein aggregates aremarked by stars (red). (C)WT and TRC8-KO hepatocytes were treatedwith 400 μM
palmitate for indicated times. The levels of p-eIF2α, ATF4, CHOP and cleaved caspase 3 were examined by Western blot analysis. (D) Representative TUNEL stains of WT and TRC8-KO
hepatocytes treated with or without 400 μM palmitate for 24 h. Quantitative data represent mean ± SE of 3 independent experiments. *P b 0.01 vs untreated control of same genotype;
†P b 0.01 vs palmitate-treated WT cells.
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To further conﬁrm that TRC8 downregulation contributes to the aug-
mented UPR and ER stress during NASH development, we assessed theeffect of a chemical chaperone, PBA, onMCD diet-induced NASH in both
WT and TRC8-KOmice. Mice in each genotype were subjected to intra-
peritoneal injection of saline or PBA (100 mg/kg body weight) every
3 days starting from the second week and continuing until the end of
Fig. 6. TRC8 deﬁciency attenuates ER stress-induced translational suppression and misfolded protein turnover. (A) Primary WT and TRC8-KO hepatocytes were treated with or without
400 μM palmitate for 24 h, followed by puromycin (10 μg/ml) treatment for 10 min. The level of puromycin incorporated in nascent synthesized proteins was examined by Western
blot analysis. (B) Puromycin incorporation was quantiﬁed by densitometry and normalized to β-actin. The quantitative data shown are mean ± SE of 3 independent experiments.
*P b 0.05 vs WT of same treatment; †P b 0.03 vs palmitate-untreated group of same genotype. (C) WT and TRC8-KO hepatocytes were transfected with pIRES-NHK-HA for 24 h and
then treatedwith 10 μg/ml CHX for indicated times. The declines of HA-tagged ATNHKwere examined byWestern blot analysis. (D) The blots shown in (C)were quantiﬁed by densitom-
etry. Quantitative data aremean± SE of 3 independent experiments. *P b 0.05 vsWT. (E)WT and TRC8-KO hepatocyteswere transfectedwith orwithout pIRES-NHK-HA for 24 h, and cell
lysates were prepared and subjected to immunoprecipitation with anti-HA tag-resin. The level of ATNHK in whole cell lysates and the extent of ubiquitination of immunoprecipitated
ATNHK were examined byWestern blot analysis with anti-HA antibody and anti-ubiquitin antibody, respectively.
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induced body weight loss was not signiﬁcantly affected by PBA treat-
ment in either genotype (data not shown). However, liver steatosis
was substantially attenuated by PBA treatment in both MCD diet-fed
WT and TRC8-KOmice (Fig. 7B & C).Western blot analysis demonstrat-
ed that hepatic eIF2 phosphorylation and expressions of ATF4, CHOP,
and cleaved caspase 3 were markedly alleviated in both groups of
mice (Fig. 7A and Supplementary Fig. 8). Furthermore, PBA treatment
resulted in the reduction of hepatocyte apoptosis, macrophage inﬁltra-
tion, and ﬁbrosis to similar extents in both MCD diet-fed WT andTRC8-KO mice (Fig. 7B–D). These ﬁndings support the implication of
TRC8 in ER stress during NASH progression.
3.8. TRC8 exerts hepatoprotective function in vitro and in vivo
To assess the hepatoprotective function of TRC8, both cultured WT
and TRC8-KO hepatocytes were infected with control Adv or Adv-
TRC8 for 24 h and then treated with or without palmitate for indicated
times. As shown in Fig. 8A, palmitate-induced eIF2 phosphorylation and
induction of ATF4 and CHOP expression were markedly lower in both
Fig. 7. PBA attenuates NASH exacerbated by TRC8 deﬁciency inMCD diet-fedmice. WT and TRC8-KOmice were placed on chow (n= 4/each genotype) or MCD (n= 12/each genotype)
diet for 6weeks as described inMaterials andmethods. MCDdiet-treatedmice in each genotypewere divided into two groups (n=6/subgroup)with one group receiving intraperitoneal
injection of saline and another group receiving PBA (100mg/kg bodyweight) every 3 days starting from the secondweek ofMCD diet feeding. (A) Hepatic expression levels of ATF4, CHOP
and cleaved caspase 3 in various treated groups of mice were examined byWestern blot analysis. (B) Representative images of Oil Red stain, Sirius Red stain, and F4/80 immunostain of
liver sections. (C) Hepatic TG levels, macrophage contents and ﬁbrosis extents in various groups of mice were quantiﬁed. (D) Representative TUNEL stains of liver sections. Numbers of
TUNEL+-cells in various groups were determined. Quantitative data represent mean ± SE. *P b 0.01 vs chow diet-fed group of same genotype; †P b 0.01 vs MCD diet-fed WT group;
#P b 0.01 vs MCD diet-fed group of same genotype.
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cells infected with control Adv. Moreover, the caspase 3 cleavage and
apoptosis induced by palmitate were also signiﬁcantly reduced byTRC8 overexpression in WT and TRC8-KO hepatocytes (Fig. 8A & B).
To demonstrate the protective function of TRC8 in vivo, C57BL/6J mice
placed on the MCD diet for 3 weeks were subjected to intravenous
Fig. 8. TRC8 overexpression protects hepatocytes from lipotoxicity-induced apoptosis in vitro. WT and TRC8-KO hepatocytes were transfected with control Adv or Adv-TRC8 vector
(0.5MOI) for 24 h, followed by palmitate (400 μM) treatment for another 2 or 24 h. (A) Expression levels of p-eIF2α (2 h), TRC8, ATF4, CHOP and cleaved caspase 3 (24 h) post palmitate
treatment were examined byWestern blot analysis. (B) Palmitate-induced apoptosis was examined by TUNEL staining. Data shown are representative images. The numbers of TUNEL+-
cells in various treated groups were quantiﬁed. Data shown are the mean± SE of 3 independent experiments. *P b 0.01 vs untreated cells infected with same Adv; †P b 0.01 vs palmitate-
treated cells infected with control Adv.
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feeding for an additional 3 weeks before sacriﬁce. As shown in Fig. 9A
and Supplementary Fig. 9, TRC8 transgene expression was evident in
the livers of mice receiving Adv-TRC8 administration. Notably, MCD
diet-induced eIF2 phosphorylation, and increased expression of ATF4,
CHOP, and cleaved caspase 3 were signiﬁcantly reduced in the Adv-TRC8-treated group but not in the group of mice treated with control
Adv as shown in the sameﬁgures. Hepatic steatosiswasnot signiﬁcantly
affected by hepatic TRC8 overexpression (Fig. 9B & C). Nevertheless, he-
patocyte apoptosis, inﬂammation and ﬁbrosis induced by the MCD diet
were signiﬁcantly attenuated in the group of mice with hepatic TRC8
overexpression (Fig. 9B–D).
Fig. 9.Hepatic TRC8 overexpression ameliorates NASH inmice. C57BL/6Jmice were placed onMCD diet for 3weeks, followed by intravenous administration of saline, control Adv or Adv-
TRC8 at a dose of 1 × 109 pfu per mouse. Mice continued to be placed onMCD diet for additional 3 weeks prior to sacriﬁce. A group of mice fed with chow diet for 6 weeks was served as
control. (A) Hepatic expression levels of TRC8, ATF4, CHOP and cleaved caspase 3 in various treated groups ofmice were examined byWestern blot analysis. (B) Representative images of
H&E stain, Sirius Red stain, and F4/80 immunostain of liver sections. (C) Hepatic TG levels, macrophage contents andﬁbrosis extents in various groups ofmice (n=4 ~ 5mice/group)were
quantiﬁed. (D) Representative TUNEL stains of liver sections. Numbers of TUNEL+-cells in various groupswere determined (n=4 ~5mice/group).Quantitative data representmean±SE.
*P b 0.01 vs chow diet-fed group; †P b 0.01 vs saline-treated MCD diet-fed group.
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TRC8 was originally identiﬁed as a tumor suppressor in cancer.
Whether TRC8 has roles in other disease states has not been fully ex-
plored. The present study demonstrated for the ﬁrst time that TRC8 ex-
hibits a protective function in NAFLD. We showed that hepatic TRC8
expression was downregulated in steatotic livers of patients and exper-
imental animals. Subsequent experiments demonstrated that diet-induced liver injury, as reﬂected by the increased caspase 3 activation
and hepatocyte apoptosis, in mice was exacerbated by TRC8 deﬁciency.
Although earlier studies have shown that TRC8 suppresses lipid biosyn-
thesis through affecting the stabilities of SREBPs and HMG-CoA reduc-
tase [13–15], we found that the extents of hepatic steatosis induced by
the HFD or MCD diet were not signiﬁcantly different between WT and
TRC8-KO mice. We speculate that the downregulation of hepatic TRC8
expression may reduce its impact on lipid synthesis in WT mice to a
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steatosis. Nevertheless, it is apparent that TRC8 inﬂuences NAFLD pro-
gression through a pathway beyond lipid metabolism.
Compelling evidence has supported that a prolonged ER stress in-
duced by the accumulated lipotoxic fatty acids contributes to the hepat-
ic damage and the progression from simple steatosis to NASH [19,20].
However, the pathogenic mechanism underlying the persistent ER
stress during this process is not completely understood. A characteristic
feature of ER stress is the accumulation of unfolded or misfolded pro-
teins in the ER lumen, which subsequently triggers UPR response to re-
duce the protein load through inducing translational arrest and
increasing the capacity of ER to fold or degrade unfolded or misfolded
proteins. Failure of UPR to restore ERhomeostasis leads to the activation
of the apoptotic pathway via inducing CHOP expression [6]. Considering
that TRC8 is an ER-resident E3 ligase, its potential implication in ER
stress response during NASH development deserves investigation. The
present study showed that the levels of ER stress markers, including
eIF-2α phosphorylation, ATF4, GRP78 and CHOP expression, induced
in the livers of MCD diet-fed mice were much higher in TRC8-KO mice
comparing to WT controls. The pathological link between TRC8
deﬁciency and enhanced ER stress/dysfunction was further revealed
by the accumulation of more protein aggregates in the lumen of
fragmented and dilated ER in the hepatocytes of MCD diet-fed TRC8-
KOmice. On the other hand, the exacerbatedNASH induced by TRC8 de-
ﬁciency could be markedly attenuated by treatment with the chemical
chaperone, PBA. The in vivo ﬁnding was recapitulated by an in vitro
experiment showing that lipotoxic palmitate-induced ER stress re-
sponse and apoptosis were signiﬁcantly higher in primary TRC8-KO he-
patocytes than WT controls. Moreover, ectopic TRC8 overexpression
reduced lipotoxicity-induced apoptosis of hepatocytes. The hepatopro-
tective function of TRC8 was further demonstrated in the experiment
showing that adenovirus-mediated TRC8 overexpression in livers of
mice attenuates NASH development. These data support the notion
that TRC8 downregulation in steatotic liver contributes to the augment-
ed ER stress that drives the progression to NASH.
To further elucidate themechanism by which TRC8 deﬁciency exac-
erbates ER stress in steatotic liver, we assessed the protein translation in
WT and TRC8-KO hepatocytes. In agreement with the early report that
TRC8 exhibits a suppressive effect on protein translation [13], the trans-
lational activity as assessed by the incorporation of puromycin into na-
scent proteins [21] was much higher in primary TRC8-KO hepatocytes
than that of WT controls. Notably, palmitate treatment led to decreased
protein translation in bothWT and TRC8-KO hepatocytes. Nevertheless,
the protein synthesis remained much higher in TRC8-KO hepatocytes
than in WT counterparts under the lipotoxic stress condition. These
ﬁndings indicate that TRC8 downregulation or deﬁciency can cause in-
sufﬁcient attenuation of protein synthesis under ER stress, which may
contribute to the accumulation of excessive unfolded or misfolded pro-
teins within ER lumen and the prolonged UPR response in fatty liver.
Additional experiments were also performed to assess the potential
role of TRC8 involved in the removal of unfolded or misfolded proteins
accumulated in hepatocytes. Our data showed that the ubiquitination
and turnover ofmisfolded ATNHKprotein overexpressed in hepatocytes
were signiﬁcantly retarded by TRC8 deﬁciency. These ﬁndings demon-
strate an important function of TRC8 in the maintenance of ER protein
homeostasis in hepatocytes, particularly under the stress condition.
In conclusion, the present study discloses a crucial role of TRC8 in
NAFLD. Although the detailed mechanism of TRC8 downregulation in
steatotic liver remains to be clariﬁed, the reduced TRC8 expression ap-
pears to hamper the recovery of ER homeostasis from lipotoxic stress
by exacerbating the accumulation of unfolded and misfolded proteins
within ER, which subsequently activates a persistent and inappropriate
UPR response leading to severe hepatic injury. Our ﬁndings suggest thatan approach to increase TRC8 expression may provide a therapeutic
beneﬁt to control the progression of NAFLD.
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